Back to Search
Start Over
Supplementary figure 1 from Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus–Derived Vectors Fosters Dendritic Cell–Mediated T-cell Cross-Priming
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- The SFV-XF vector exerts maximal antitumor efficacy as compared to SFV vectors encoding each single transgene and is effective against B16F10-derived melanomas, PANC02 pancreatic cancer and CT26 colon cancer.
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....a323637805eca0af6e0a39bb8848554c
- Full Text :
- https://doi.org/10.1158/0008-5472.22418867.v1